tm logo
LFB USA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 24 May 2023

Last Applicant/ Owned by

Serial Number

86206216 filed on 27th Feb 2014

Registration Number

5082582 registered on 15th Nov 2016

in the Principal Register

Correspondent Address

Luna M. Samman

Luna M. Samman

1717 K St., NW

WASHINGTON, DC 20006-5344

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LFB USA

Pharmaceutical, [ biosimilar,] biopharmaceutical, [ and veterinary] preparations for the treatment of [cancer,] blood diseases, [auto-immune diseases, infectious diseases,] and hereditary diseases

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical, [ biosimilar,] biopharmaceutical, [ and veterinary] preparations for the treatment of [cancer,] blood diseases, [auto-immune diseases, infectious diseases,] and hereditary diseases


First Use Date in General

24th Dec 2015

First Use Date in Commerce

24th Dec 2015

Specimens


LFB USA specimenLFB USA specimenLFB USA specimenLFB USA specimenLFB USA specimenLFB USA specimenLFB USA specimenLFB USA specimenLFB USA specimen

Mark Details


Serial Number

No 86206216

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 009930.00024

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th May 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24th May 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
24th May 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Nov 2022TEAS SECTION 8 & 15 RECEIVED
15th Nov 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
15th Nov 2016REGISTERED-PRINCIPAL REGISTER
12th Oct 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11th Oct 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23rd Sep 2016STATEMENT OF USE PROCESSING COMPLETE
13th Sep 2016USE AMENDMENT FILED